ORKANasdaqPharmaceutical PreparationsFiscal year ends December 31
Oruka Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$74.48+2.55 (+3.55%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Sep 3, 2024 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| May 8, 2019(first seen in filings) | 1-for-18 reverse | Earlier per-share figures multiplied by 18 |
| Apr 4, 2019 | 1-for-18 reverse | Earlier per-share figures multiplied by 18 |
| Sep 30, 2015 | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |
| Sep 4, 2015 | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |
| Mar 5, 2013 | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |
| Dec 31, 2012 | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |
| Jan 28, 2009 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Feb 23, 2004 | 1-for-3 reverse | Earlier per-share figures multiplied by 3 |